Bill > HR7418

This bill amends the Internal Revenue Code of 1986 to exclude from gross income certain compensation received by individuals for participating in approved clinical trials. Specifically, it establishes a new section (139J) that defines "qualified clinical trial payments" as compensation for an individual's participation in an approved clinical trial, or reimbursement of reasonable and necessary expenses incurred in connection with such participation. An "approved clinical trial" is defined by reference to the Public Health Service Act, with the key change being that the definition is expanded beyond "life-threatening" diseases or conditions. This exclusion from gross income would apply to payments made after December 31, 2023.